1. Home
  2. AYTU
  3. AYTU News

Latest Aytu BioPharma Inc. (AYTU) News on October 6, 2024

AYTU

ACCESSWIRE

5 days ago

Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Canada

Aytu BioPharma Full Year 2024 Earnings: EPS Misses Expectations
AYTU

Simply Wall St.

8 days ago

Aytu BioPharma Full Year 2024 Earnings: EPS Misses Expectations

AYTU

Thomson Reuters StreetEvents

9 days ago

Q4 2024 Aytu Biopharma Inc Earnings Call

AYTU

ACCESSWIRE

9 days ago

Aytu BioPharma Reports Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results

Aytu BioPharma to Report Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results on September 26, 2024
AYTU

ACCESSWIRE

16 days ago

Aytu BioPharma to Report Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results on September 26, 2024

Analysts Expect Breakeven For Aytu BioPharma, Inc. (NASDAQ:AYTU) Before Long
AYTU

Simply Wall St.

a month ago

Analysts Expect Breakeven For Aytu BioPharma, Inc. (NASDAQ:AYTU) Before Long

Aytu BioPharma to Participate in the Sidoti Micro-Cap Virtual Conference on August 14-15, 2024
AYTU

ACCESSWIRE

2 months ago

Aytu BioPharma to Participate in the Sidoti Micro-Cap Virtual Conference on August 14-15, 2024

Aytu BioPharma Announces Sale of Consumer Health Business Following Wind Down of Consumer Health Operations
AYTU

ACCESSWIRE

2 months ago

Aytu BioPharma Announces Sale of Consumer Health Business Following Wind Down of Consumer Health Operations

Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now
AYTU

GlobeNewswire

3 months ago

Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now

It's Unlikely That The CEO Of Aytu BioPharma, Inc. (NASDAQ:AYTU) Will See A Huge Pay Rise This Year
AYTU

Simply Wall St.

4 months ago

It's Unlikely That The CEO Of Aytu BioPharma, Inc. (NASDAQ:AYTU) Will See A Huge Pay Rise This Year

Aytu BioPharma Announces Paydown and Refinancing of Term Loan on More Favorable Terms
AYTU

ACCESSWIRE

4 months ago

Aytu BioPharma Announces Paydown and Refinancing of Term Loan on More Favorable Terms

Lytham Partners Spring 2024 Investor Conference Starts Tomorrow, May 30, 2024
AYTU

Newsfile

4 months ago

Lytham Partners Spring 2024 Investor Conference Starts Tomorrow, May 30, 2024

Aytu BioPharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
AYTU

ACCESSWIRE

4 months ago

Aytu BioPharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

AYTU

Thomson Reuters StreetEvents

5 months ago

Q3 2024 Aytu Biopharma Inc Earnings Call

AYTU

GuruFocus.com

5 months ago

Aytu BioPharma Inc (AYTU) Q3 2024 Earnings Call Transcript Highlights: Strategic Gains Amidst ...

Aytu BioPharma Reports Fiscal 2024 Third Quarter Operational and Financial Results
AYTU

ACCESSWIRE

5 months ago

Aytu BioPharma Reports Fiscal 2024 Third Quarter Operational and Financial Results

Aytu BioPharma to Report Third Quarter Fiscal 2024 Financial and Operational Results on May 15, 2024
AYTU

ACCESSWIRE

5 months ago

Aytu BioPharma to Report Third Quarter Fiscal 2024 Financial and Operational Results on May 15, 2024

Aytu BioPharma to Present at the Emerging Growth Conference on April 4, 2024
AYTU

ACCESSWIRE

6 months ago

Aytu BioPharma to Present at the Emerging Growth Conference on April 4, 2024

Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now
AYTU

GlobeNewswire

6 months ago

Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now

Aytu BioPharma, Inc. (NASDAQ:AYTU) Q2 2024 Earnings Call Transcript
AYTU

Insider Monkey

8 months ago

Aytu BioPharma, Inc. (NASDAQ:AYTU) Q2 2024 Earnings Call Transcript

Aytu BioPharma Second Quarter 2024 Earnings: Beats Expectations
AYTU

Simply Wall St.

8 months ago

Aytu BioPharma Second Quarter 2024 Earnings: Beats Expectations

AYTU

Thomson Reuters StreetEvents

8 months ago

Q2 2024 Aytu Biopharma Inc Earnings Call

Aytu BioPharma Reports Record ADHD Revenue and Operating Income During Fiscal 2024 Second Quarter
AYTU

ACCESSWIRE

8 months ago

Aytu BioPharma Reports Record ADHD Revenue and Operating Income During Fiscal 2024 Second Quarter

Aytu BioPharma to Report Second Quarter Fiscal 2024 Financial and Operational Results on February 14, 2024
AYTU

ACCESSWIRE

8 months ago

Aytu BioPharma to Report Second Quarter Fiscal 2024 Financial and Operational Results on February 14, 2024

LAVA Therapeutics Announces Collaboration with Merck & Co., Inc., Rahway, NJ, USA to Evaluate LAVA-1207 in Combination with KEYTRUDA®
AYTU

GlobeNewswire

8 months ago

LAVA Therapeutics Announces Collaboration with Merck & Co., Inc., Rahway, NJ, USA to Evaluate LAVA-1207 in Combination with KEYTRUDA®

Clene VISIONARY-MS Trial Data May Support CNM-Au8(R) as MS Treatment
AYTU

NewMediaWire

8 months ago

Clene VISIONARY-MS Trial Data May Support CNM-Au8(R) as MS Treatment

SYLA Technologies Enters into a “Capital and Business Alliance Agreement” with RIBERESUTE
AYTU

GlobeNewswire

8 months ago

SYLA Technologies Enters into a “Capital and Business Alliance Agreement” with RIBERESUTE

Aytu BioPharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024
AYTU

ACCESSWIRE

8 months ago

Aytu BioPharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

Bionano Announces Full Commercial Release of the Stratys™ System for High Throughput Optical Genome Mapping
AYTU

GlobeNewswire

8 months ago

Bionano Announces Full Commercial Release of the Stratys™ System for High Throughput Optical Genome Mapping

AYTU

Reuters

9 months ago

GRAPHIC-As price parity beckons, substitution from palladium to platinum to wane

When Will Aytu BioPharma, Inc. (NASDAQ:AYTU) Become Profitable?
AYTU

Simply Wall St.

9 months ago

When Will Aytu BioPharma, Inc. (NASDAQ:AYTU) Become Profitable?

FAT Brands (FAT) Unveils First Co-Branded Los Angeles Location
AYTU

Zacks

9 months ago

FAT Brands (FAT) Unveils First Co-Branded Los Angeles Location

AYTU

GlobeNewswire

9 months ago

Acri Capital Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination

At the 2024 Golden Globes, Diamonds Were Forever
AYTU

WWD

9 months ago

At the 2024 Golden Globes, Diamonds Were Forever

MicroAlgo Inc. Developed QSDLT to Provide a More Secure Foundation for Bitcoin and Other Cryptocurrency Systems
AYTU

PR Newswire

9 months ago

MicroAlgo Inc. Developed QSDLT to Provide a More Secure Foundation for Bitcoin and Other Cryptocurrency Systems

Is it a Good Idea to Sell Sterling Bancorp (SBT) Now?
AYTU

Insider Monkey

9 months ago

Is it a Good Idea to Sell Sterling Bancorp (SBT) Now?

2 Small Cap Stocks That Could Go Parabolic in 2024, According to Wall Street
AYTU

Motley Fool

9 months ago

2 Small Cap Stocks That Could Go Parabolic in 2024, According to Wall Street

G. Willi-Food International Third Quarter 2023 Earnings: EPS: ₪0.35 (vs ₪0.55 in 3Q 2022)
AYTU

Simply Wall St.

9 months ago

G. Willi-Food International Third Quarter 2023 Earnings: EPS: ₪0.35 (vs ₪0.55 in 3Q 2022)

Cardio Diagnostics Holdings, Inc. Appoints Biotechnology Investor, Executive & Serial Entrepreneur Paul Burton to its Board of Directors
AYTU

Business Wire

9 months ago

Cardio Diagnostics Holdings, Inc. Appoints Biotechnology Investor, Executive & Serial Entrepreneur Paul Burton to its Board of Directors

AYTU

Business Wire

10 months ago

Innovative Solutions & Support, Inc. Announces Fourth Quarter and Full Year Fiscal 2023 Financial Results

Fossil Group (NASDAQ:FOSL) adds US$10m to market cap in the past 7 days, though investors from five years ago are still down 90%
AYTU

Simply Wall St.

10 months ago

Fossil Group (NASDAQ:FOSL) adds US$10m to market cap in the past 7 days, though investors from five years ago are still down 90%

Red Cat Holdings Reports Financial Results for Fiscal Second Quarter 2024 and Provides Corporate Update
AYTU

GlobeNewswire

10 months ago

Red Cat Holdings Reports Financial Results for Fiscal Second Quarter 2024 and Provides Corporate Update

Ekso Bionics Receives CMS Coding Approval for Ekso Indego Personal
AYTU

GlobeNewswire

10 months ago

Ekso Bionics Receives CMS Coding Approval for Ekso Indego Personal

AYTU

Business Wire

10 months ago

Innovative Solutions & Support, Inc. Announces Fourth Quarter and Full Year Fiscal 2023 Earnings Conference Call

Hyliion Holdings Corp. (NYSE: HYLN) to Host Tech Fireside Chat Showcasing KARNO Linear Generator Technology on December 12th
AYTU

Business Wire

10 months ago

Hyliion Holdings Corp. (NYSE: HYLN) to Host Tech Fireside Chat Showcasing KARNO Linear Generator Technology on December 12th

Presenting on the Emerging Growth Conference 65 Day 2 on December 7th Register Now
AYTU

GlobeNewswire

10 months ago

Presenting on the Emerging Growth Conference 65 Day 2 on December 7th Register Now

Declining Stock and Solid Fundamentals: Is The Market Wrong About Innovative Solutions and Support, Inc. (NASDAQ:ISSC)?
AYTU

Simply Wall St.

10 months ago

Declining Stock and Solid Fundamentals: Is The Market Wrong About Innovative Solutions and Support, Inc. (NASDAQ:ISSC)?

Envoy Medical to Host Fireside Chat Event December 7
AYTU

GlobeNewswire

10 months ago

Envoy Medical to Host Fireside Chat Event December 7

Noodles & Company (NASDAQ:NDLS) has caught the attention of institutional investors who hold a sizeable 44% stake
AYTU

Simply Wall St.

10 months ago

Noodles & Company (NASDAQ:NDLS) has caught the attention of institutional investors who hold a sizeable 44% stake

Aytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023
AYTU

ACCESSWIRE

10 months ago

Aytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023

Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
AYTU

GlobeNewswire

10 months ago

Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX nsPFA Percutaneous Electrode
AYTU

Business Wire

10 months ago

Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX nsPFA Percutaneous Electrode

Aytu BioPharma, Inc. (NASDAQ:AYTU) Q1 2024 Earnings Call Transcript
AYTU

Insider Monkey

a year ago

Aytu BioPharma, Inc. (NASDAQ:AYTU) Q1 2024 Earnings Call Transcript

Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results
AYTU

ACCESSWIRE

a year ago

Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results

AYTU

Thomson Reuters StreetEvents

a year ago

Q3 2023 Celcuity Inc Earnings Call

Clearside Biomedical Announces Third Quarter 2023 Financial Results and Provides Corporate Update
AYTU

GlobeNewswire

a year ago

Clearside Biomedical Announces Third Quarter 2023 Financial Results and Provides Corporate Update

AYTU

GuruFocus.com

a year ago

Celcuity Inc (CELC) Reports Q3 2023 Financial Results and Strategic Developments

Sypris Wins Award for Cryptographic Program
AYTU

Business Wire

a year ago

Sypris Wins Award for Cryptographic Program

Celcuity Inc. Reports Third Quarter 2023 Financial Results and Provides Corporate Updates
AYTU

GlobeNewswire

a year ago

Celcuity Inc. Reports Third Quarter 2023 Financial Results and Provides Corporate Updates

Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Third Consecutive Year
AYTU

ACCESSWIRE

a year ago

Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Third Consecutive Year

Rapid Micro Biosystems to Participate in Upcoming Investor Conferences
AYTU

GlobeNewswire

a year ago

Rapid Micro Biosystems to Participate in Upcoming Investor Conferences

Aytu BioPharma to Report First Quarter Fiscal 2024 Financial Results on November 14, 2023
AYTU

ACCESSWIRE

a year ago

Aytu BioPharma to Report First Quarter Fiscal 2024 Financial Results on November 14, 2023

Actinium Presents Preclinical Data at SITC Demonstrating Actimab-A's Potential to Restore T Cell Immunity in the Solid Tumor Microenvironment Supporting Immunotherapy Combinations
AYTU

PR Newswire

a year ago

Actinium Presents Preclinical Data at SITC Demonstrating Actimab-A's Potential to Restore T Cell Immunity in the Solid Tumor Microenvironment Supporting Immunotherapy Combinations

Share on Social Networks: